{"id":71441,"date":"2026-05-20T11:35:00","date_gmt":"2026-05-20T11:35:00","guid":{"rendered":"https:\/\/medsbase.com\/hmg-peptide\/"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"hmg-peptide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/hmg-peptide\/","title":{"rendered":"HMG (Human Menopausal Gonadotropin \/ Menotropin) \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is HMG (pharmaceutical-grade)?<\/h3>\n<p style=\"margin: 0;\"><strong>HMG<\/strong> (\u30d2\u30c8\u9589\u7d4c\u671f\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u3001\u5225\u540d <strong>\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3<\/strong>; CAS 61489-71-2\uff09\u306f\u3001LH\u3068FSH\u306e\u751f\u7269\u6d3b\u6027\u3092\u7b49\u91cf\u542b\u3080\u5c3f\u7531\u6765\u306e\u7cd6\u30bf\u30f3\u30d1\u30af\u30db\u30eb\u30e2\u30f3\u88fd\u5264\u3067\u3059\uff081\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308a75 IU LH + 75 IU FSH\u3001\u6a19\u6e96\u7684\u306a1:1\u6bd4\u7387\uff09\u3002\u9589\u7d4c\u5f8c\u5973\u6027\u306e\u5c3f\u304b\u3089\u7cbe\u88fd\u3055\u308c\u305f\u3082\u306e\u3067 \u2014 \u4e0b\u5782\u4f53\u6027\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u5206\u6ccc\u304c\u30cd\u30ac\u30c6\u30a3\u30d6\u30d5\u30a3\u30fc\u30c9\u30d0\u30c3\u30af\u6291\u5236\u306e\u6b20\u5982\u306b\u3088\u308a\u81ea\u7136\u306b\u4e0a\u6607\u3057\u3066\u3044\u308b \u2014 hMG\u306f\u3001\u53e4\u5178\u7684\u306a <strong>LHCGR\u3068FSHR\u306e\u4e8c\u91cd\u30a2\u30b4\u30cb\u30b9\u30c8<\/strong> in endocrine pharmacology and the reference tool for protocols that need simultaneous Leydig-cell \/ theca-cell steroidogenesis (LH side) and Sertoli-cell \/ granulosa-cell action (FSH side). The supplied pharmaceutical-grade material is the urinary-extracted glycoform at \u226599% HPLC purity. <em>For clinical studies use only.<\/em> \u81e8\u5e8a\u7528\u306e\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3\u88fd\u5264\uff08Menopur\u3001Menogon\u3001Repronex\uff09\u3068\u306f\u7570\u306a\u308a\u307e\u3059\u3002<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5316\u5408\u7269\u30af\u30e9\u30b9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u7cd6\u30bf\u30f3\u30d1\u30af\u30db\u30eb\u30e2\u30f3\u88fd\u5264 \u2014 LH\u3068FSH\u306e\u751f\u7269\u6d3b\u6027\u306e1\uff1a1\u56fa\u5b9a\u6df7\u5408\u7269\uff1bLH\/CG\u53d7\u5bb9\u4f53\uff08LHCGR\uff09\u3068FSH\u53d7\u5bb9\u4f53\uff08FSHR\uff09\u306e\u4e8c\u91cd\u30a2\u30b4\u30cb\u30b9\u30c8\uff1b\u30da\u30d7\u30c1\u30c9\u30db\u30eb\u30e2\u30f3\u88fd\u5264<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5316\u5b66\u540d<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u30d2\u30c8\u9589\u7d4c\u671f\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\uff08\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3\uff1b\u5c3f\u62bd\u51fa\u88fd\u5264\uff1b\u5225\u540d\uff1ahMG\u3001urofollitropin-with-LH\u3001\u9589\u7d4c\u671f\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">61489-71-2\uff08\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3\uff0fhMG\u6df7\u5408\u88fd\u5264\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6709\u52b9\u6210\u5206<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>LH<\/strong> \uff08\u9ec4\u4f53\u5f62\u6210\u30db\u30eb\u30e2\u30f3\u3001\u7d0430 kDa\u306e\u30d8\u30c6\u30ed\u4e8c\u91cf\u4f53\uff1b\u03b1\u30b5\u30d6\u30e6\u30cb\u30c3\u30c892\u30a2\u30df\u30ce\u9178 + \u03b2\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8121\u30a2\u30df\u30ce\u9178\u3001\u7cd6\u9396\u4fee\u98fe\uff09 \u2014 1\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308a75 IU\uff1b; <strong>FSH<\/strong> \uff08\u5375\u80de\u523a\u6fc0\u30db\u30eb\u30e2\u30f3\u3001\u7d0430 kDa\u306e\u30d8\u30c6\u30ed\u4e8c\u91cf\u4f53\uff1b\u03b1\u30b5\u30d6\u30e6\u30cb\u30c3\u30c892\u30a2\u30df\u30ce\u9178 + \u03b2\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8111\u30a2\u30df\u30ce\u9178\u3001\u7cd6\u9396\u4fee\u98fe\uff09 \u2014 1\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308a75 IU\u3002\u03b1\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8\u306fLH\u3001FSH\u3001HCG\u3001TSH\u306e\u9593\u3067\u5171\u901a\u3067\u3042\u308a\u3001\u03b2\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8\u304c\u53d7\u5bb9\u4f53\u7279\u7570\u6027\u3092\u4ed8\u4e0e\u3057\u307e\u3059\u3002\u4e21\u65b9\u306e\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u306f\u3001\u5e83\u7bc4\u306bN-\u304a\u3088\u3073O-\u30b0\u30ea\u30b3\u30b7\u30eb\u5316\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u751f\u7269\u6d3b\u6027\u6bd4<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">LH:FSH\u6d3b\u6027\u6bd4 = 1:1\uff081990\u5e74\u4ee3\u5f8c\u534a\u306e\u529b\u4fa1\u6a19\u6e96\u5316\u4ee5\u964d\u306e\u6a19\u6e96\u7684\u306ahMG\u6bd4\u3002\u4e21\u6d3b\u6027\u306fWHO\u30d0\u30a4\u30aa\u30a2\u30c3\u30bb\u30a4\u306b\u3088\u308a\u56fd\u969b\u53c2\u7167\u6a19\u6e96\u306b\u5bfe\u3057\u3066\u6e2c\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>HCG Co-Purification (studies-relevant)<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u5c3f\u7531\u6765hMG\u88fd\u5264\u306e\u7279\u5fb4\uff1a\u516c\u8868\u3055\u308c\u305f\u7d44\u6210\u5206\u6790\u3067\u306f\u3001\u7d04 <strong>\u751f\u4f53\u5185LH\u53d7\u5bb9\u4f53\u4ecb\u5728\u6027\u751f\u7269\u6d3b\u6027\u306e95%\u306f\u3001\u9589\u7d4c\u5f8c\u5c3f\u304b\u3089\u5171\u7cbe\u88fd\u3055\u308c\u305f\u5fae\u91cf\u306eHCG\u306b\u8d77\u56e0\u3057\u307e\u3059\u3002<\/strong> (Wolfenson et\u00a0al. 2005 and others). HCG and LH bind the same LHCGR with similar affinity, but HCG has 33\u201337 h half-life vs LH&#8217;s ~20 min \u2014 so even small HCG amounts dominate the in-vivo LH-equivalent signal. Users should be aware of this when comparing hMG to pure recombinant LH (Luveris) preparations.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4f5c\u7528\u6a5f\u5e8f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u4e8c\u91cdGPCR\u30a2\u30b4\u30cb\u30ba\u30e0\u3002 <strong>LHCGR<\/strong> \uff08Gs\u5171\u5f79\u3001\u30e9\u30a4\u30c7\u30a3\u30c3\u30d2\u7d30\u80de\uff0f\u83a2\u819c\u7d30\u80de\uff0f\u9846\u7c92\u819c\u7d30\u80de\uff0f\u9ec4\u4f53\u7d30\u80de\uff09\u2192 cAMP-PKA-StAR-CYP17A1\u30ab\u30b9\u30b1\u30fc\u30c9 \u2192 \u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u751f\u5408\u6210\u3002 <strong>FSHR<\/strong> \uff08Gs\u5171\u5f79\u3001\u7537\u6027\u3067\u306f\u30bb\u30eb\u30c8\u30ea\u7d30\u80de\uff0f\u5973\u6027\u3067\u306f\u9846\u7c92\u819c\u7d30\u80de\uff09\u2192 cAMP-PKA-CYP19A1\/\u30a2\u30ed\u30de\u30bf\u30fc\u30bc\u30ab\u30b9\u30b1\u30fc\u30c9 \u2192 \u7cbe\u5b50\u5f62\u6210\u652f\u6301\uff08\u7537\u6027\uff09\u307e\u305f\u306f\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u304b\u3089\u30a8\u30b9\u30c8\u30ed\u30b2\u30f3\u3078\u306e\u5909\u63db\uff0b\u5375\u80de\u6210\u719f\uff08\u5973\u6027\uff09\u3002\u3053\u306e\u4e8c\u91cd\u6d3b\u6027\u5316\u304c\u3001hMG\u3092\u7d14\u7c8bLH\uff08Luveris\uff0frLH\uff09\u3084\u7d14\u7c8bFSH\uff08Gonal-F\uff0fPuregon\uff0frFSH\uff09\u88fd\u5264\u3068\u533a\u5225\u3059\u308b\u70b9\u3067\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u6df7\u5408\u88fd\u5264 \u2014 LH\u3068FSH\u306f\u3069\u3061\u3089\u3082\u30d8\u30c6\u30ed\u4e8c\u91cf\u4f53\u7cd6\u30bf\u30f3\u30d1\u30af\u8cea\u3067\u3059\u3002\u03b1\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8\uff08\u5171\u901a\uff09\u306f\u7d0492\u30a2\u30df\u30ce\u9178\u3067\u3001LH\/FSH\/HCG\/TSH\u9593\u3067\u540c\u4e00\u3067\u3059\u3002LH \u03b2\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8\u306f\u7d04121\u30a2\u30df\u30ce\u9178\u3001FSH \u03b2\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8\u306f\u7d04111\u30a2\u30df\u30ce\u9178\u3067\u3059\u3002\u5b8c\u5168\u306a\u914d\u5217\u306fUniProt\u304b\u3089\u5165\u624b\u53ef\u80fd\u3067\u3059\uff1aLH\u03b2\uff08P01229\uff09\u3001FSH\u03b2\uff08P01225\uff09\u3001GPH\u03b1\uff08P01215\uff09\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u5c3f\u7531\u6765\u6df7\u5408\u7cd6\u30bf\u30f3\u30d1\u30af\u8cea\u88fd\u5264 \u2014 FSH\uff08\u03b1 92aa + \u03b2 111aa\uff09\u3068LH\uff08\u03b1 92aa + \u03b2 121aa\uff09\u306e\u30d8\u30c6\u30ed\u4e8c\u91cf\u4f53\u304c\u3001\u751f\u7269\u6d3b\u6027\u6bd4\u7d041:1\u3067\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u88fd\u5264\u5168\u4f53\u306b\u308f\u305f\u308b\u4e0d\u5747\u4e00\u306a\u30b0\u30ea\u30b3\u30b7\u30eb\u5316\u30d1\u30bf\u30fc\u30f3\u306e\u305f\u3081\u3001\u5358\u4e00\u306e\u5206\u5b50\u5f0f\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u8840\u6f3f\u4e2d\u534a\u6e1b\u671f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">FSH\u6d3b\u6027\uff1a\u7d42\u672b\u534a\u6e1b\u671f\u306f\u7d0430\uff5e40\u6642\u9593\uff08\u30b7\u30a2\u30eb\u9178\u4fee\u98fe\u306b\u4f9d\u5b58\u3057\u3001\u4ed6\u306e\u7cd6\u30bf\u30f3\u30d1\u30af\u8cea\u30db\u30eb\u30e2\u30f3\u3068\u540c\u69d8\uff09\u3002hMG\u4e2d\u306eLH\u6d3b\u6027\uff1a\u540d\u76ee\u4e0a\u306f\u7d0410\uff5e20\u6642\u9593\uff08\u305f\u3060\u3057\u5b9f\u969b\u306b\u306f\u3001\u5171\u7cbe\u88fd\u3055\u308c\u305fHCG\u753b\u5206\u306e\u534a\u6e1b\u671f33\uff5e37\u6642\u9593\u306b\u4f9d\u5b58\u3057\u307e\u3059 \u2014 \u4e0a\u8a18\u306eHCG\u5171\u7cbe\u88fd\u306b\u95a2\u3059\u308b\u6ce8\u8a18\u3092\u53c2\u7167\uff09\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized white-to-off-white amorphous powder with mannitol or lactose stabilising matrix; single-use vials<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\uff09\uff1bWHO\u30d0\u30a4\u30aa\u30a2\u30c3\u30bb\u30a4\u306b\u3088\u308a\u3001\u8868\u793a\u901a\u308a\u306eLH\u304a\u3088\u3073FSH\u6d3b\u6027\uff08\u540475 IU\uff09\u304c\u78ba\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5206\u6790\u8a3c\u660e\u66f8\uff08COA\uff09\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\u53ef\u80fd\u3067\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308a1.0 mL\u306e\u9759\u83cc\u6c34\u3067\u6eb6\u89e3 \u2192 75 IU LH + 75 IU FSH\/mL\u306e\u4f5c\u696d\u539f\u6db2\uff1b\u305d\u306e\u4ed6\u306e\u5e0c\u91c8\u306f\u30d7\u30ed\u30c8\u30b3\u30eb\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u30b1\u30fc\u30ad\u306f\u7a4f\u3084\u304b\u306b\u65cb\u56de\u3055\u305b\u308b\u3053\u3068\u3067\u901f\u3084\u304b\u306b\u6eb6\u89e3\u3057\u307e\u3059\u3002 <strong>\u632f\u3068\u3046\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff1b\u30dc\u30eb\u30c6\u30c3\u30af\u30b9\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002<\/strong> \u2014 \u9ad8\u526a\u65ad\u6df7\u5408\u306f\u3001LH\u304a\u3088\u3073FSH\u6210\u5206\u306e\u03b1\/\u03b2\u30d8\u30c6\u30ed\u4e8c\u91cf\u4f53\u3092\u89e3\u96e2\u3055\u305b\u307e\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u672a\u958b\u5c01\u3067\u77ed\u671f\u4f5c\u696d\u7528\u306b\u306f2\uff5e8 \u00b0C\uff1b\u9577\u671f\u4fdd\u5b58\u306b\u306f\u221220 \u00b0C\uff08\u221220 \u00b0C\u306736\u304b\u6708\u4ee5\u4e0a\u5b89\u5b9a\uff1b2\uff5e8 \u00b0C\u306718\u304b\u6708\u4ee5\u4e0a\u5b89\u5b9a\uff09\u3002\u6eb6\u89e3\u5f8c\uff1a2\uff5e8 \u00b0C\u3067\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u6eb6\u89e3\u5f8c\u306e\u6750\u6599\u3092\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002<\/strong> \u2014 \u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u3001LH\u304a\u3088\u3073FSH\u306e\u03b1\/\u03b2\u30d8\u30c6\u30ed\u4e8c\u91cf\u4f53\u3092\u89e3\u96e2\u3055\u305b\u3001\u751f\u7269\u6d3b\u6027\u3092\u7834\u58ca\u3057\u307e\u3059\u3002<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>HMG\uff08\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3\uff09\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h2>\n<p><strong>HMG<\/strong> \u2014 \u30d2\u30c8\u9589\u7d4c\u671f\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u3001\u5225\u540d <strong>\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3<\/strong> (CAS 61489-71-2) \u2014 is a urinary-derived glycoprotein-hormone preparation containing equal amounts of LH (luteinising hormone) and FSH (follicle-stimulating hormone) bioactivity, standardised at 75 IU of each per vial. It is purified by ion-exchange and gel-filtration chromatography from the pooled urine of postmenopausal women, who have naturally elevated pituitary gonadotropin output (LH and FSH typically 50\u2013100+ mIU\/mL each) due to the loss of ovarian negative-feedback inhibition that accompanies menopause. The &#8220;menopausal&#8221; in the name refers to this source: postmenopausal urine is the most concentrated natural source of LH and FSH available for industrial-scale purification, and hMG has been produced from this source since the early 1960s (the original Cesare Serono-developed Pergonal preparation). The compositional refinement of hMG has evolved substantially over the decades \u2014 earlier preparations had highly variable LH:FSH ratios and significant protein-impurity loads; modern preparations (the basis of our pharmaceutical-grade material) are standardised at 75:75 IU bioactivity per vial with \u226599% HPLC purity. hMG is the canonical dual-gonadotropin pharmacological tool. Where HCG selectively activates the LHCGR, where pure-LH (recombinant Luveris) selectively activates the LHCGR at physiological half-life, where pure-FSH (recombinant Gonal-F \/ Puregon) selectively activates the FSHR, hMG activates both receptors simultaneously at a fixed 1:1 ratio. The two receptors are expressed on different cell populations within the gonad \u2014 LHCGR on Leydig cells \/ theca cells \/ luteinised granulosa \/ corpus luteum; FSHR on Sertoli cells \/ mural granulosa \u2014 so dual activation produces a complete physiological gonadotropin stimulus that more closely mimics endogenous mid-cycle pituitary output than either receptor activated alone. <strong>A studies-relevant nuance: HCG co-purification.<\/strong> Published compositional analyses of urinary-derived hMG preparations report that the bulk of the in-vivo LH-receptor bioactivity is actually attributable to trace HCG co-purified from postmenopausal urine \u2014 approximately 95% of LH-receptor-mediated bioactivity by some analyses (Wolfenson et\u00a0al., 2005). This is because HCG and LH bind the same LHCGR with similar affinity, but HCG has 33\u201337 h plasma half-life versus LH&#8217;s ~20 min, so even small HCG amounts dominate the cumulative in-vivo LH-equivalent signal. This is part of why hMG produces sustained Leydig-cell stimulation despite the nominal &#8220;LH activity&#8221; of LH itself being short-lived. For protocols where this distinction matters (pure-LH pharmacology vs HCG-contaminated mixed-LH signal), recombinant LH (Luveris) is the cleaner tool; for protocols where dual LHCGR + FSHR activation at physiological 1:1 ratio is the goal, hMG is the canonical reference. <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 LHCGR + FSHR \u306e\u4e8c\u91cd\u6d3b\u6027\u5316<\/h2>\n<p>hMG\u306e\u4f5c\u7528\u6a5f\u5e8f\u306f\u3001\u5185\u5206\u6ccc\u85ac\u7406\u5b66\u3067\u5341\u5206\u306b\u89e3\u660e\u3055\u308c\u3066\u3044\u308b2\u3064\u306e\u69cb\u6210\u6d3b\u6027\u306e\u4e8c\u91cd\u306e\u7dcf\u548c\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>LH\uff08\u304a\u3088\u3073\u5171\u7cbe\u88fd\u3055\u308c\u305fHCG\uff09\u2192 LHCGR\u6d3b\u6027\u5316<\/strong> \u2014 LH\u6210\u5206\uff08\u304a\u3088\u3073\u9589\u7d4c\u5f8c\u5973\u6027\u306e\u5c3f\u304b\u3089\u5171\u7cbe\u88fd\u3055\u308c\u308b\u5fae\u91cf\u306eHCG\uff09\u306f\u3001\u7cbe\u5de3\u306e\u30e9\u30a4\u30c7\u30a3\u30c3\u30d2\u7d30\u80de\u304a\u3088\u3073\u5375\u5de3\u306e\u83a2\u819c\/\u9846\u7c92\u819c\/\u9ec4\u4f53\u7d30\u80de\u4e0a\u306eLH\/CG\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3057\u307e\u3059\u3002Gs\u5171\u5f79\u306b\u3088\u308acAMP\u304c\u4e0a\u6607\u3057\u3001PKA\u3092\u6d3b\u6027\u5316\u3057\u3001StAR\u3092\u4ecb\u3057\u305f\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u306e\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u8f38\u9001\u3092\u4ea2\u9032\u3055\u305b\u3001CYP11A1 \/ CYP17A1 \/ 3\u03b2-HSD \/ 17\u03b2-HSD\u306a\u3069\u306e\u30b9\u30c6\u30ed\u30a4\u30c9\u5408\u6210\u9175\u7d20\u3092\u8a98\u5c0e\u3057\u3001\u7d50\u679c\u3068\u3057\u3066\u30c6\u30b9\u30c8\u30b9\u30c6\u30ed\u30f3\u306ede novo\u751f\u5408\u6210\uff08\u7537\u6027\uff09\u307e\u305f\u306f\u30a2\u30f3\u30c9\u30ed\u30b9\u30c6\u30f3\u30b8\u30aa\u30f3\u306e\u751f\u5408\u6210\uff08\u5973\u6027\uff09\u3092\u4fc3\u9032\u3057\u307e\u3059\u3002<\/li>\n<li><strong>FSH \u2192 FSHR\u6d3b\u6027\u5316<\/strong> \u2014 FSH\u6210\u5206\u306f\u3001\u7cbe\u5de3\u306e\u30bb\u30eb\u30c8\u30ea\u7d30\u80de\u3068\u5375\u5de3\u306e\u58c1\u9846\u7c92\u819c\u7d30\u80de\u4e0a\u306eFSH\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3057\u307e\u3059\u3002FSHR\u3082Gs\u5171\u5f79\u578b\u3067\u3059\u304c\u3001\u4e0b\u6d41\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u7570\u306a\u308a\u307e\u3059\u3002\u30bb\u30eb\u30c8\u30ea\u7d30\u80de\u3067\u306fFSHR\u6d3b\u6027\u5316\u304c\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u7d50\u5408\u30bf\u30f3\u30d1\u30af\u8cea\uff08ABP\uff09\u3001\u30a4\u30f3\u30d2\u30d3\u30f3B\u3001\u304a\u3088\u3073\u7cbe\u5b50\u5f62\u6210\u3092\u652f\u3048\u308b\u69cb\u9020\u7684\u652f\u6301\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u4fc3\u9032\u3057\u307e\u3059\u3002\u9846\u7c92\u819c\u7d30\u80de\u3067\u306fFSHR\u6d3b\u6027\u5316\u304cCYP19A1\uff08\u30a2\u30ed\u30de\u30bf\u30fc\u30bc\uff09\u3092\u4fc3\u9032\u3057\u3001\u5375\u80de\u819c\u7d30\u80de\u7531\u6765\u306e\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u3092\u30a8\u30b9\u30c8\u30ed\u30b2\u30f3\u306b\u5909\u63db\u3057\u3001\u80de\u72b6\u5375\u80de\u671f\u304b\u3089\u6392\u5375\u524d\u671f\u307e\u3067\u306e\u5375\u80de\u6210\u719f\u3092\u4fc3\u9032\u3057\u307e\u3059\u3002<\/li>\n<li><strong>2\u7d30\u80de2\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u30e2\u30c7\u30eb<\/strong> \u2014 \u53e4\u5178\u7684\u306a\u5185\u5206\u6ccc\u5b66\u306e\u67a0\u7d44\u307f\u3067\u3059\u3002\u7537\u6027\u7cbe\u5de3\u3067\u306f\u3001LH\u523a\u6fc0\u3092\u53d7\u3051\u305f\u30e9\u30a4\u30c7\u30a3\u30c3\u30d2\u7d30\u80de\u304c\u30c6\u30b9\u30c8\u30b9\u30c6\u30ed\u30f3\u3092\u7523\u751f\u3057\u3001\u3053\u308c\u304c\u96a3\u63a5\u3059\u308b\u30bb\u30eb\u30c8\u30ea\u7d30\u80de\u306b\u62e1\u6563\u3057\u3001\u305d\u3053\u3067FSH\u8a98\u5c0e\u6027\u306e\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u7d50\u5408\u30bf\u30f3\u30d1\u30af\u8cea\u3068\u30bb\u30eb\u30c8\u30ea\u7d30\u80de\u306e\u4ee3\u8b1d\u6a5f\u69cb\u304c\u3001\u7cbe\u5b50\u5f62\u6210\u306b\u5fc5\u8981\u306a\u9ad8\u6fc3\u5ea6\u7cbe\u5de3\u5185\u30c6\u30b9\u30c8\u30b9\u30c6\u30ed\u30f3\u5fae\u5c0f\u74b0\u5883\u3078\u3068\u5909\u63db\u3057\u307e\u3059\u3002\u5973\u6027\u5375\u5de3\u3067\u306f\u3001LH\u523a\u6fc0\u3092\u53d7\u3051\u305f\u5375\u80de\u819c\u7d30\u80de\u304c\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u3092\u7523\u751f\u3057\u3001\u3053\u308c\u304c\u96a3\u63a5\u3059\u308b\u9846\u7c92\u819c\u7d30\u80de\u306b\u62e1\u6563\u3057\u3001FSH\u8a98\u5c0e\u6027\u306e\u30a2\u30ed\u30de\u30bf\u30fc\u30bc\u304c\u3053\u308c\u3092\u30a8\u30b9\u30c8\u30ed\u30b2\u30f3\u306b\u5909\u63db\u3057\u307e\u3059\u30022\u7d30\u80de2\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u30e2\u30c7\u30eb\u306f\u6a19\u6e96\u7684\u306a\u67a0\u7d44\u307f\u3067\u3042\u308a\u3001hMG\u306f\u305d\u306e\u4e21\u65b9\u3092\u540c\u6642\u306b\u6d3b\u6027\u5316\u3059\u308b\u305f\u3081\u306e\u6a19\u6e96\u7684\u306a\u85ac\u7406\u5b66\u7684\u30c4\u30fc\u30eb\u3067\u3059\u3002<\/li>\n<li><strong>\u53d7\u5bb9\u4f53\u8131\u611f\u4f5c\u3068\u30bf\u30ad\u30d5\u30a3\u30e9\u30ad\u30b7\u30fc<\/strong> \u2014 Both LHCGR and FSHR undergo arrestin-mediated desensitization after sustained agonist exposure. Repeated high-dose hMG dosing can produce receptor downregulation \u2014 a well-documented phenomenon in published gonadotropin-pharmacology studies relevant to chronic-dosing protocols.<\/li>\n<li><strong>\u8996\u5e8a\u4e0b\u90e8-\u4e0b\u5782\u4f53\u30d5\u30a3\u30fc\u30c9\u30d0\u30c3\u30af<\/strong> \u2014 As with HCG, hMG-driven gonadal steroid output feeds back to the hypothalamus and pituitary to suppress endogenous GnRH and LH\/FSH secretion. In the context of HPG-suppression studies (testosterone replacement, AAS exposure, pharmacological GnRH antagonism), hMG bypasses the hypothalamic-pituitary blockade by acting directly at the gonadal receptors \u2014 preserving both Leydig-cell function (LH side) and Sertoli-cell \/ spermatogenesis-support function (FSH side) simultaneously, which is what distinguishes hMG from pure-HCG protocols in this context.<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of hMG broadly mirrors that of its components: FSH activity persists with 30\u201340 h terminal half-life, LH-equivalent activity is dominated by the long-half-life co-purified HCG (33\u201337 h), and the combined preparation produces sustained 24\u201372 h dual gonadotropin stimulation per dose. Typical protocol dosing is 75\u2013225 IU SC daily in rodent or human-subject studies \u2014 equivalent to 1\u20133 vials of the 75 IU strength. <\/p>\n<h2>Published Evidence<\/h2>\n<p>hMG is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u85ac\u7406\u5b66 \u2014 \u6a19\u6e96\u7684\u306a\u4e8c\u91cd\u53d7\u5bb9\u4f53\u30ea\u30d5\u30a1\u30ec\u30f3\u30b9<\/strong> \u2014 most-cited dual LHCGR + FSHR agonist in published gonadotropin studies; standard reference compound for dissecting LH-only vs FSH-only vs combined gonadotropin signalling<\/li>\n<li><strong>Spermatogenesis induction studies<\/strong> \u2014 in hypogonadotropic-hypogonadism rodent models, hMG (with or without supplementary HCG) is the canonical tool for inducing spermatogenesis by restoring both Leydig-cell testosterone production and Sertoli-cell FSH support; standard protocol cycle is 75\u2013150 IU SC three times per week for 6\u201324 months in clinical-translational studies<\/li>\n<li><strong>Female ovarian-stimulation studies<\/strong> \u2014 the historical foundation tool of in-vitro fertilisation studies; hMG drives follicular development through the antral and pre-ovulatory stages in published ovulation-induction protocols, typically combined with HCG as ovulation trigger; widely used in studies on polycystic ovary syndrome (PCOS), unexplained infertility, and assisted reproductive technologies<\/li>\n<li><strong>Two-cell two-gonadotropin model studies<\/strong> \u2014 the canonical framework of gonadal steroidogenesis pharmacology; hMG is the standard tool for activating both halves of the model simultaneously; published Sertoli-Leydig co-culture and theca-granulosa co-culture uses hMG to recapitulate the physiological dual-receptor stimulus<\/li>\n<li><strong>HPG-axis suppression-recovery<\/strong> \u2014 in published studies models where endogenous LH\/FSH has been suppressed (by exogenous testosterone, AAS exposure, or GnRH antagonism), hMG preserves both Leydig-cell function and Sertoli-cell function by direct gonadal receptor activation \u2014 distinguishing it from HCG-only protocols which preserve only LH-side function and risk Sertoli-cell atrophy<\/li>\n<li><strong>\u7d14\u7c8bLH \/ \u7d14\u7c8bFSH \/ HCG \u3068\u306e\u6bd4\u8f03\u85ac\u7406\u5b66<\/strong> \u2014 hMG\u3068\u3001\u907a\u4f1d\u5b50\u7d44\u63db\u3048LH\uff08\u30eb\u30d9\u30ea\u30b9\uff09\u3001\u907a\u4f1d\u5b50\u7d44\u63db\u3048FSH\uff08\u30b4\u30ca\u30fc\u30eb\u30a8\u30d5 \/ \u30d4\u30e5\u30a2\u30b4\u30f3\uff09\u3001\u907a\u4f1d\u5b50\u7d44\u63db\u3048HCG\uff08\u30aa\u30d3\u30c9\u30ec\u30eb\uff09\u3001\u304a\u3088\u3073\u69d8\u3005\u306a\u7d44\u307f\u5408\u308f\u305b\u3068\u306e\u76f4\u63a5\u6bd4\u8f03\u8a66\u9a13\u304c\u6570\u591a\u304f\u767a\u8868\u3055\u308c\u3066\u3044\u307e\u3059\u3002hMG\u306f\u3001\u3053\u308c\u3089\u3059\u3079\u3066\u306e\u30d9\u30f3\u30c1\u30de\u30fc\u30af\u3068\u306a\u308b\u5c3f\u7531\u67651:1\u6df7\u5408\u30ea\u30d5\u30a1\u30ec\u30f3\u30b9\u88fd\u5264\u3067\u3059<\/li>\n<li><strong>\u5375\u80de\u767a\u80b2\u304a\u3088\u3073\u9846\u7c92\u819c\u7d30\u80de\u751f\u7269\u5b66<\/strong> \u2014 published ex-vivo follicular culture and primary granulosa-cell uses hMG to drive simultaneous theca-cell androgen production and granulosa-cell aromatase induction \u2014 the most physiologically relevant in-vitro stimulus available<\/li>\n<li><strong>\u9ec4\u4f53\u751f\u7269\u5b66<\/strong> \u2014 sustained LHCGR activation by the LH component (and co-purified HCG) maintains corpus-luteum function and progesterone production; used in studies on the luteal phase and luteo-placental transition<\/li>\n<\/ul>\n<p>For broader context on HPG-axis and reproductive-system peptides in this catalogue, see <a href=\"https:\/\/medsbase.com\/ja\/hcg-peptide\/\">HCG\uff08\u30d2\u30c8\u7d68\u6bdb\u6027\u6027\u817a\u523a\u6fc0\u30db\u30eb\u30e2\u30f3\uff09<\/a> \uff08\u7d14\u7c8b\u306aLHCGR\u30a2\u30b4\u30cb\u30b9\u30c8 \u2014 \u76f4\u63a5\u6bd4\u8f03\u5bfe\u8c61\u3002LH\u5074\u6d3b\u6027\u306e\u307f\uff09\u3001, <a href=\"https:\/\/medsbase.com\/ja\/kisspeptin-10\/\">\u30ad\u30b9\u30da\u30d7\u30c1\u30f3-10<\/a> \uff08\u8996\u5e8a\u4e0b\u90e8\u306e\u4e0a\u6d41Kiss1R\u30a2\u30b4\u30cb\u30b9\u30c8 \u2014 \u5185\u56e0\u6027GnRH\u62cd\u52d5\u6027\u3092\u99c6\u52d5\uff09\u3001, <a href=\"https:\/\/medsbase.com\/ja\/pt-141\/\">PT-141\uff08\u30d6\u30ec\u30e1\u30e9\u30ce\u30c1\u30c9\uff09<\/a> (melanocortin-receptor pharmacology \u2014 sexual-function studies), and <a href=\"https:\/\/medsbase.com\/ja\/oxytocin-acetate\/\">\u30aa\u30ad\u30b7\u30c8\u30b7\u30f3\u9162\u9178\u5869<\/a> \uff08\u4e0b\u5782\u4f53\u5f8c\u8449\u30da\u30d7\u30c1\u30c9\u30db\u30eb\u30e2\u30f3\uff09\u3002\u5168\u88fd\u54c1\u3092\u898b\u308b <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">peptides &amp; compounds catalog<\/a>. <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u529b\u4fa1\u3068\u6fc3\u5ea6<\/h2>\n<p>MedsBase stocks HMG (urinary-extracted menotropin) in a single lyophilized vial strength calibrated to the standard 1:1 LH:FSH bioactivity unit. The vial is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u529b\u4fa1<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>75 IU LH + 75 IU FSH<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength (the international-reference unit dose) \u2014 single-dose dual-gonadotropin stimulation, spermatogenesis-induction protocols (75\u2013225 IU SC three times per week), ovarian-stimulation studies, two-cell two-gonadotropin co-culture stimulation, comparative pharmacology vs recombinant pure-LH and pure-FSH preparations<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The 75:75 IU vial is the international-reference dose unit and the format used in essentially all published gonadotropin studies and clinical practice. Multiple-vial dosing (150 IU, 225 IU per administration) is standard for higher-dose protocols. The 30-vial pack is the more economical purchase per-IU for extended-cycle or multi-cohort protocols. <\/p>\n<h2>\u6bd4\u8f03 \u2014 HMG vs HCG<\/h2>\n<p><a href=\"https:\/\/medsbase.com\/ja\/hcg-peptide\/\">HCG<\/a> \u3068hMG\u306f\u3001\u5f53\u30ab\u30bf\u30ed\u30b0\u306b\u63b2\u8f09\u3055\u308c\u3066\u3044\u308b2\u3064\u306e\u5c3f\u7531\u6765\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u88fd\u5264\u3067\u3042\u308a\u3001\u4f5c\u7528\u6a5f\u69cb\u306e\u7570\u306a\u308b\u65b9\u6cd5\u3067\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u53d7\u5bb9\u4f53\u30b7\u30b9\u30c6\u30e0\u3092\u6a19\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002HCG\u306f <em>\u7d14\u7c8b\u306a<\/em> LH\/CG\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac \u2014 \u30e9\u30a4\u30c7\u30a3\u30c3\u30d2\u7d30\u80de\uff0f\u83a2\u819c\u7d30\u80de\u306e\u6d3b\u6027\u5316\u306e\u307f\u3002hMG\u306f <em>\u4e8c\u5143<\/em> LH + FSH preparation \u2014 engages both halves of the two-cell two-gonadotropin model simultaneously. The choice between them in studies depends on whether the protocol needs LH-side activation alone or combined LH-side + FSH-side activation. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">HMG\uff08\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3\uff09<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">HCG<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u7d44\u6210<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1\u306e\u56fa\u5b9a\u6df7\u5408\uff1a\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308aLH 75 IU + FSH 75 IU\uff08+ \u4f53\u5185\u3067LH\u76f8\u5f53\u306e\u30b7\u30b0\u30ca\u30eb\u3092\u512a\u4f4d\u306b\u3059\u308b\u5fae\u91cf\u306eHCG\u3092\u542b\u3080\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u7cbe\u88fdHCG\uff08\u5c3f\u7531\u6765\uff09\u2014 \u5358\u4e00\u306e\u7cd6\u30bf\u30f3\u30d1\u30af\u8cea<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u95a2\u4e0e\u3059\u308b\u53d7\u5bb9\u4f53<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">LHCGR <em>KYC\uff08Know Your Customer\uff09<\/em> FSHR \u2014 2\u3064\u306e\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u53d7\u5bb9\u4f53\u306e\u6d3b\u6027\u5316<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">LHCGR\u306e\u307f \u2014 \u5358\u4e00\u306e\u53d7\u5bb9\u4f53<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u51fa\u5178<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u9589\u7d4c\u5f8c\u5973\u6027\u306e\u5c3f<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u598a\u5a66\u5c3f\uff08uHCG\uff09\u307e\u305f\u306f\u907a\u4f1d\u5b50\u7d44\u63db\u3048CHO\u7d30\u80de\uff08rHCG\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best applications<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Spermatogenesis induction (preserves Sertoli-cell function), ovarian follicular stimulation, two-cell two-gonadotropin model studies, dual-receptor pharmacology<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Leydig-cell-only stimulation, ovulation triggering (LH-surge mimic), Leydig-cell-specific HPG-suppression-recovery, LHCGR pharmacology<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u8840\u6f3f\u4e2d\u534a\u6e1b\u671f<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">FSH \u7d0430\uff5e40\u6642\u9593\uff1bLH\u76f8\u5f53\u6d3b\u6027\u306f\u5171\u7cbe\u88fdHCG\uff0833\uff5e37\u6642\u9593\uff09\u304c\u4e3b\u4f53<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">33\uff5e37\u6642\u9593\uff08\u7d42\u672b\u76f8\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e00\u822c\u7684\u306a\u7528\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u56de\u3042\u305f\u308a75\uff5e225 IU SC\uff081\uff5e3\u30d0\u30a4\u30a2\u30eb\uff09\uff1b\u6162\u6027\u30d7\u30ed\u30c8\u30b3\u30fc\u30eb\u3067\u306f\u90313\u56de<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">500\uff5e5,000 IU SC \/ IM\uff08\u5358\u56de\u30dc\u30fc\u30e9\u30b9\uff09\uff1b\u6162\u6027\u30d7\u30ed\u30c8\u30b3\u30fc\u30eb\u3067\u306f250\uff5e500 IU\/\u65e5<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u30d0\u30a4\u30a2\u30eb\u6295\u4e0e\u5358\u4f4d<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">75 IU\u751f\u7269\u6d3b\u6027\uff08\u56fd\u969b\u57fa\u6e96\u5358\u4f4d\u7528\u91cf\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5,000\u307e\u305f\u306f10,000 IU\u751f\u7269\u6d3b\u6027<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>WADA\u30b9\u30c6\u30fc\u30bf\u30b9<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u7537\u6027\u30a2\u30b9\u30ea\u30fc\u30c8\u306f\u5e38\u6642\u7981\u6b62\uff08S2 \u2014 \u30da\u30d7\u30c1\u30c9\u30db\u30eb\u30e2\u30f3\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u7537\u6027\u30a2\u30b9\u30ea\u30fc\u30c8\u306f\u5e38\u6642\u7981\u6b62\uff08S2 \u2014 \u30da\u30d7\u30c1\u30c9\u30db\u30eb\u30e2\u30f3\uff09\uff1b\u5973\u6027\u30a2\u30b9\u30ea\u30fc\u30c8\u306f\u9069\u7528\u9664\u5916<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on dual LHCGR + FSHR activation, spermatogenesis induction, or the canonical two-cell two-gonadotropin model, hMG is the standard reference compound. For studies focused on Leydig-cell-only stimulation, ovulation triggering, or HCG-specific LHCGR pharmacology, <a href=\"https:\/\/medsbase.com\/ja\/hcg-peptide\/\">HCG<\/a> \u3088\u308a\u6a19\u7684\u3092\u7d5e\u3063\u305f\u30c4\u30fc\u30eb\u3067\u3059\u3002\u3053\u3061\u3089\u3082\u3054\u89a7\u304f\u3060\u3055\u3044 <a href=\"https:\/\/medsbase.com\/ja\/kisspeptin-10\/\">\u30ad\u30b9\u30da\u30d7\u30c1\u30f3-10<\/a> for upstream hypothalamic Kiss1R \/ GnRH-pulsatility studies. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 BAC\u6c34\u304c\u5fc5\u8981\u3067\u3059\u304b\uff1f<\/strong> \u51cd\u7d50\u4e7e\u71e5\u54c1\u306e\u5fa9\u5143\u306b\u306f\u6ec5\u83cc\u9759\u83cc\u6c34\u304c\u5fc5\u8981\u3067\u3059\u3002\u672c\u88fd\u54c1\u3068\u4f75\u305b\u3066\u5f53\u793e\u306e <a href=\"\/ja\/bac-water\/\"><strong>BAC Water\uff08\u9759\u83cc\u6c34\uff09<\/strong><\/a> \u2014 30 mL\u30de\u30eb\u30c1\u30c9\u30fc\u30ba\u30d0\u30a4\u30a2\u30eb\u30010.9%\u30d9\u30f3\u30b8\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u4fdd\u5b58\u3001USP\u30b0\u30ec\u30fc\u30c9\u3002<\/div>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f\u3001\u77ed\u671f\u4f7f\u7528\u306e\u30ef\u30fc\u30ad\u30f3\u30b0\u30b9\u30c8\u30c3\u30af\u3068\u3057\u3066\u3001\u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8 \u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u9577\u671f\u4fdd\u5b58\u306e\u5834\u5408\u306f\u3001\u672a\u958b\u5c01\u306e\u30d0\u30a4\u30a2\u30eb\u3092\u221220 \u00b0C\u3067\u51cd\u7d50\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\uff08\u221220 \u00b0C\u306736\u304b\u6708\u4ee5\u4e0a\u5b89\u5b9a\uff1b2\uff5e8 \u00b0C\u306718\u304b\u6708\u4ee5\u4e0a\u5b89\u5b9a\uff09\u3002\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306f\u30de\u30f3\u30cb\u30c8\u30fc\u30eb\u307e\u305f\u306f\u30e9\u30af\u30c8\u30fc\u30b9\u3067\u5b89\u5b9a\u5316\u3055\u308c\u3066\u304a\u308a\u3001\u53d6\u308a\u6271\u3044\u4e2d\u306e\u77ed\u6642\u9593\u306e\u5ba4\u6e29\u66b4\u9732\u306b\u306f\u3042\u308b\u7a0b\u5ea6\u8010\u6027\u304c\u3042\u308a\u307e\u3059\u304c\u3001\u901f\u3084\u304b\u306b\u51b7\u8535\u306b\u623b\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> for each 75 IU vial, inject 1.0\u00a0mL of bacteriostatic water down the side wall of the vial (not directly onto the lyophilized cake) \u2014 this yields a working stock of 75 IU LH + 75 IU FSH per mL. For protocols that need higher concentrations (multi-vial pooling for higher single-dose), reconstitute 2\u20133 vials with the same 1.0\u00a0mL diluent total to give 150\u2013225 IU\/mL. <strong>\u9759\u304b\u306b\u56de\u3057\u3066\u6eb6\u304b\u3057\u3066\u304f\u3060\u3055\u3044 \u2014 \u632f\u3089\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3001\u30dc\u30eb\u30c6\u30c3\u30af\u30b9\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002<\/strong> \u9ad8\u526a\u65ad\u6df7\u5408\u306f\u3001LH\u304a\u3088\u3073FSH\u6210\u5206\u306e\u4e21\u65b9\u306e\u03b1\/\u03b2\u30d8\u30c6\u30ed\u4e8c\u91cf\u4f53\u3092\u89e3\u96e2\u3055\u305b\u3001\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u53d7\u5bb9\u4f53\u306e\u751f\u7269\u6d3b\u6027\u3092\u7834\u58ca\u3057\u307e\u3059\u3002\u30de\u30f3\u30cb\u30c8\u30fc\u30eb\u30d9\u30fc\u30b9\u306e\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306f\u3001\u901a\u5e38\u3001\u9759\u304b\u306b\u56de\u3059\u3053\u3068\u306730\u301c60\u79d2\u4ee5\u5185\u306b\u6eb6\u89e3\u3057\u307e\u3059\u3002 <strong>\u518d\u69cb\u6210\u5f8c\u306e\u91cd\u8981\u306a\u4fdd\u5b58\u30eb\u30fc\u30eb\uff1a<\/strong> \u518d\u69cb\u6210\u5f8c\u306f\u30012\uff5e8 \u00b0C\u3067\u4fdd\u5b58\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u69cb\u6210\u3057\u305fhMG\u3092\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044<\/strong> \u2014 freeze-thaw cycles dissociate the LH and FSH \u03b1\/\u03b2 heterodimers (the same physical-chemistry constraint as HCG) and irreversibly destroy bioactivity. Protect from light. Discard if cloudiness, particulates, or marked colour change appears. For protocols requiring multiple aliquots, prepare aliquots at the time of reconstitution and store at 2\u20138 \u00b0C separately rather than freezing. <\/p>\n<h2>\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>HMG\u3068HCG\u306e\u9055\u3044\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p><a href=\"https:\/\/medsbase.com\/ja\/hcg-peptide\/\">HCG<\/a> is a pure LH\/CG-receptor agonist \u2014 single glycoprotein hormone (CAS 9002-61-3) that binds and activates only the LHCGR on Leydig \/ theca \/ granulosa \/ luteal cells. hMG is a 1:1 mixture of LH and FSH bioactivity \u2014 distinct glycoprotein hormones (combined CAS 61489-71-2) that bind both the LHCGR (LH side) and the FSHR (FSH side). The clinical and studies consequence is that hMG produces dual-receptor stimulation that engages both halves of the two-cell two-gonadotropin model (Leydig + Sertoli in males; theca + granulosa in females), where HCG produces single-receptor stimulation of the LHCGR side only. <\/p>\n<h3>What is the HCG co-purification in hMG, and why does it matter for studies?<\/h3>\n<p>\u5c3f\u7531\u6765hMG\u88fd\u5264\u306e\u516c\u8868\u3055\u308c\u305f\u7d44\u6210\u5206\u6790\u3067\u306f\u3001 <strong>\u751f\u4f53\u5185LH\u53d7\u5bb9\u4f53\u4ecb\u5728\u6027\u751f\u7269\u6d3b\u6027\u306e95%<\/strong> is actually attributable to trace HCG co-purified from postmenopausal urine, rather than to LH itself (Wolfenson et\u00a0al., 2005). This is because HCG and LH bind the same LHCGR with similar affinity, but HCG has 33\u201337 h plasma half-life vs LH&#8217;s ~20 min \u2014 so even small amounts of co-purified HCG dominate the cumulative in-vivo LH-equivalent signal. For protocols where this distinction matters (e.g., comparing pure-LH pharmacology vs HCG-contaminated mixed-LH signal), <strong>\u7d44\u63db\u3048LH\uff08Luveris\uff09<\/strong> \u3088\u308a\u7d14\u7c8b\u306a\u30c4\u30fc\u30eb\u3067\u3059\u3002LHCGR\u3068FSHR\u306e\u4e21\u65b9\u3092\u56fa\u5b9a\u306e1:1\u6bd4\u3067\u6d3b\u6027\u5316\u3055\u305b\u308b\u3053\u3068\u304c\u76ee\u7684\u306e\u30d7\u30ed\u30c8\u30b3\u30eb\u3067\u306f\u3001hMG\u304c\u6a19\u6e96\u7684\u306a\u53c2\u7167\u3067\u3059\u3002 <\/p>\n<h3>\u306a\u305chMG\u306f\u9589\u7d4c\u5f8c\u5973\u6027\u306e\u5c3f\u304b\u3089\u63a1\u53d6\u3055\u308c\u308b\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u9589\u7d4c\u5f8c\u5973\u6027\u3067\u306f\u3001\u5375\u5de3\u306b\u3088\u308b\u8996\u5e8a\u4e0b\u90e8-\u4e0b\u5782\u4f53\u8ef8\u3078\u306e\u30cd\u30ac\u30c6\u30a3\u30d6\u30d5\u30a3\u30fc\u30c9\u30d0\u30c3\u30af\u6291\u5236\u304c\u5931\u308f\u308c\u308b\u305f\u3081\u3001\u4e0b\u5782\u4f53\u304b\u3089\u306eLH\u304a\u3088\u3073FSH\u306e\u5206\u6ccc\u304c\u5287\u7684\u306b\u5897\u52a0\u3057\u307e\u3059\u3002\u9589\u7d4c\u5f8c\u306e\u8840\u6e05LH\u304a\u3088\u3073FSH\u306f\u901a\u5e38\u305d\u308c\u305e\u308c50\u301c100 mIU\/mL\u4ee5\u4e0a\u3067\u3001\u9589\u7d4c\u524d\u306e\u5024\u3088\u308a\u4e00\u6841\u9ad8\u304f\u306a\u308a\u307e\u3059\u3002\u305d\u306e\u5f8c\u3001\u4e21\u30db\u30eb\u30e2\u30f3\u306f\u814e\u81d3\u3092\u4ecb\u3057\u3066\u6fc3\u7e2e\u3055\u308c\u305f\u5f62\u3067\u5c3f\u4e2d\u306b\u6392\u6cc4\u3055\u308c\u307e\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u30d7\u30fc\u30eb\u3055\u308c\u305f\u9589\u7d4c\u5f8c\u5973\u6027\u306e\u5c3f\u306f\u3001\u5de5\u696d\u898f\u6a21\u306e\u62bd\u51fa\u306b\u3068\u3063\u3066\u6700\u3082\u6fc3\u7e2e\u3055\u308c\u305f\u5929\u7136\u306eLH+FSH\u6e90\u3068\u306a\u308a\u307e\u3059\u3002hMG\u7523\u696d\u306f\u3053\u306e\u6d1e\u5bdf\u306b\u57fa\u3065\u3044\u30661960\u5e74\u4ee3\u521d\u982d\u306b\u69cb\u7bc9\u3055\u308c\uff08Pergonal\u304c\u6700\u521d\u306eSerono\u88fd\u5264\u3067\u3057\u305f\uff09\u3001\u73fe\u5728\u3082\u7d9a\u3044\u3066\u3044\u307e\u3059\u304c\u3001\u81e8\u5e8a\u5e02\u5834\u306e\u591a\u304f\u306f\u7d44\u63db\u3048\u7d14\u7c8bLH\u88fd\u5264\u304a\u3088\u3073\u7d14\u7c8bFSH\u88fd\u5264\u3078\u3068\u79fb\u884c\u3057\u3066\u3044\u307e\u3059\u3002 <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Single-dose protocol use is typically 75\u2013225 IU SC per administration (1\u20133 vials of the 75 IU strength), with 3\u00d7\/week or daily dosing in chronic protocols. Spermatogenesis-induction protocols in published hypogonadotropic-hypogonadism studies typically use 75\u2013150 IU 3\u00d7\/week for 6\u201324 months in combination with HCG (the HCG provides additional Leydig-cell stimulation). In-vitro Sertoli-cell or granulosa-cell culture protocols typically use 1\u201310 IU\/mL in growth medium. Users should consult primary literature appropriate to the species, model, and endpoint. <\/p>\n<h3>hMG\u3068\u7d14\u7c8b\u306a\u7d44\u63db\u3048FSH\uff08Gonal-F \/ Puregon\uff09\u306e\u9055\u3044\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u907a\u4f1d\u5b50\u7d44\u63db\u3048FSH\uff08\u30d5\u30a9\u30ea\u30c8\u30ed\u30d4\u30f3 \u30a2\u30eb\u30d5\u30a1\uff0fGonal-F\u3001\u30d5\u30a9\u30ea\u30c8\u30ed\u30d4\u30f3 \u30d9\u30fc\u30bf\uff0fPuregon\u3001\u30af\u30ed\u30fc\u30f3\u5316FSH\u03b1\u9396\u304a\u3088\u3073\u03b2\u9396cDNA\u304b\u3089CHO\u7d30\u80de\u3067\u7523\u751f\uff09\u306b\u306f <em>\u306e\u307f<\/em> FSH bioactivity \u2014 no LH, no HCG. hMG contains both LH and FSH bioactivity at 1:1 ratio (plus trace HCG). For protocols that need pure FSHR activation isolated from LHCGR signalling, recombinant FSH is the correct tool. For protocols that need combined dual-receptor activation at physiological ratio, hMG is the correct tool. Published head-to-head trials in ovarian-stimulation have compared the two with broadly equivalent follicular-development endpoints but with subtly different oestradiol-response profiles (hMG tends to produce slightly higher mid-cycle oestradiol due to the LH-side androgen substrate it provides for granulosa-cell aromatase). <\/p>\n<h3>\u306a\u305c\u6eb6\u89e3\u3057\u305fhMG\u306f\u51cd\u7d50\u3067\u304d\u306a\u3044\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p>HCG\u3068\u540c\u3058\u7406\u7531\u3067\u3059\u3002LH\u3068FSH\u306f\u3069\u3061\u3089\u3082\u3001\u975e\u5171\u6709\u7d50\u5408\u3067\u4f1a\u5408\u3057\u305f2\u3064\u306e\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8\uff08\u03b1\u9396\u3068\u03b2\u9396\uff09\u304b\u3089\u306a\u308b\u30d8\u30c6\u30ed\u4e8c\u91cf\u4f53\u3067\u3059\u3002\u03b1\/\u03b2\u76f8\u4e92\u4f5c\u7528\u306f\u3001\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u4e2d\u3067\u306f\u5b89\u5b9a\u3067\u3042\u308a\uff08\u76f8\u4e92\u4f5c\u7528\u3092\u7834\u58ca\u3059\u308b\u6c34\u304c\u306a\u3044\u305f\u3081\uff09\u30012\uff5e8 \u00b0C\u306e\u51b7\u8535\u6c34\u6eb6\u6db2\u4e2d\u3067\u3082\u5b89\u5b9a\u3057\u3066\u3044\u307e\u3059\uff08\u4f4e\u6e29\u3067\u306f\u89e3\u96e2\u306e\u901f\u5ea6\u8ad6\u304c\u9045\u3044\u305f\u3081\uff09\u3002\u3057\u304b\u3057\u3001\u51cd\u7d50\u4e2d\u306b\u6c37\u6676\u304c\u5f62\u6210\u3055\u308c\u308b\u3068\u3001\u7269\u7406\u7684\u306b\u30b5\u30d6\u30e6\u30cb\u30c3\u30c8\u304c\u5f15\u304d\u96e2\u3055\u308c\u3001\u89e3\u51cd\u6642\u306b\u52b9\u7387\u7684\u306b\u518d\u4f1a\u5408\u3067\u304d\u307e\u305b\u3093\u3002\u305d\u306e\u7d50\u679c\u3001\u51cd\u7d50\u878d\u89e3\u3057\u305fhMG\u306f\u514d\u75ab\u53cd\u5fdc\u6027\u306e\u5927\u90e8\u5206\u3092\u4fdd\u6301\u3057\u307e\u3059\u304c\u3001\u751f\u7269\u6d3b\u6027\u306e\u591a\u304f\u3092\u5931\u3044\u307e\u3059\u3002\u51cd\u7d50\u4e7e\u71e5hMG\u306f\u51cd\u7d50\u53ef\u80fd\u3067-20 \u00b0C\u3067\u5b89\u5b9a\u3067\u3059\u304c\u3001\u6eb6\u89e3\u5f8c\u306ehMG\u306f\u51cd\u7d50\u3067\u304d\u307e\u305b\u3093\u3002 <\/p>\n<h3>hMG\u306eWADA\u306b\u304a\u3051\u308b\u898f\u5236\u72b6\u6cc1\u306f\uff1f<\/h3>\n<p>hMG \/ menotropin is on the World Anti-Doping Agency (WADA) Prohibited List under class S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics). It is prohibited at all times \u2014 both in-competition and out-of-competition \u2014 for male athletes. Users conducting human-subject studies with hMG need to be aware of this regulatory status. For clinical in-vitro and rodent in-vivo studies the WADA status is informational only. <\/p>\n<h3>How does this pharmaceutical-grade hMG compare with the branded clinical preparations (Menopur, Menogon, Repronex)?<\/h3>\n<p>The branded clinical preparations are urinary-extracted menotropin (Menopur, Menogon, Repronex; the historical Pergonal preparation has been largely discontinued) packaged under various manufacturer SKUs for clinical use in assisted reproductive technologies. The pharmaceutical-grade hMG supplied here is the same urinary-extracted preparation at \u226599% HPLC purity, supplied without a clinical-use label and intended for clinical studies only. Users seeking clinical-use menotropin should obtain it through a clinical supply chain; users seeking pharmaceutical-grade material for in-vitro receptor pharmacology, rodent in-vivo work, or other clinical applications can use the material supplied here. <\/p>\n<h3>Can hMG be combined with HCG, Kisspeptin-10, or testosterone in protocols?<\/h3>\n<p>Yes \u2014 these compounds target different layers of the HPG axis and are commonly combined in published studies. The most-published combinations are hMG + HCG (the standard clinical and protocol for spermatogenesis induction in hypogonadotropic-hypogonadism models \u2014 hMG provides FSH-side support, additional HCG provides supplemental LH-side stimulation); hMG + <a href=\"https:\/\/medsbase.com\/ja\/kisspeptin-10\/\">\u30ad\u30b9\u30da\u30d7\u30c1\u30f3-10<\/a> (upstream + downstream dissection \u2014 kisspeptin drives endogenous GnRH while hMG provides direct gonadal stimulation); hMG + exogenous testosterone (for HPG-suppression-recovery, where the testosterone suppresses endogenous LH\/FSH and hMG bypasses the suppression by acting directly at the gonad). Reconstitute each separately and follow each compound&#8217;s specific storage rules \u2014 neither hMG nor HCG should be frozen reconstituted. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for HPG-Axis and Reproductive Studies<\/h2>\n<ul>\n<li><a href=\"\/ja\/hcg-peptide\/\"><strong>HCG\uff08\u30d2\u30c8\u7d68\u6bdb\u6027\u6027\u817a\u523a\u6fc0\u30db\u30eb\u30e2\u30f3\uff09<\/strong><\/a> \u2014 \u7d14\u7c8b\u306aLH\/CG\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac \u2014 \u76f4\u63a5\u6bd4\u8f03\u7528\uff1bLH\u5074\u306e\u6d3b\u6027\u306e\u307f<\/li>\n<li><a href=\"\/ja\/kisspeptin-10\/\"><strong>\u30ad\u30b9\u30da\u30d7\u30c1\u30f3-10<\/strong><\/a> \u2014 \u8996\u5e8a\u4e0b\u90e8Kiss1R\u4f5c\u52d5\u85ac \u2014 \u4e0a\u6d41\u306eHPG\u8ef8\u8abf\u7bc0\u56e0\u5b50\u3001GnRH\u306e\u30d1\u30eb\u30b9\u6027\u5206\u6ccc\u3092\u4fc3\u9032<\/li>\n<li><a href=\"\/ja\/pt-141\/\"><strong>PT-141\uff08\u30d6\u30ec\u30e1\u30e9\u30ce\u30c1\u30c9\uff09<\/strong><\/a> \u2014 Melanocortin-4 receptor agonist \u2014 sexual-function studies<\/li>\n<li><a href=\"\/ja\/oxytocin-acetate\/\"><strong>\u30aa\u30ad\u30b7\u30c8\u30b7\u30f3\u9162\u9178\u5869<\/strong><\/a> \u2014 Posterior pituitary nonapeptide \u2014 reproductive and social bonding<\/li>\n<li><a href=\"\/ja\/tesamorelin\/\"><strong>Tesamorelin<\/strong><\/a> \u2014 GHRH\u30a2\u30ca\u30ed\u30b0 \u2014 \u7570\u306a\u308b\u5185\u5206\u6ccc\u8ef8\u3001\u591a\u304f\u306e\u7814\u7a76\u3067\u4f75\u7528<\/li>\n<li><a href=\"\/ja\/bac-water\/\"><strong>BAC Water\uff08\u9759\u83cc\u6c34\uff09<\/strong><\/a> \u2014 \u5168\u3066\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306e\u518d\u6eb6\u89e3\u306b\u5fc5\u8981 \u2014 \u7121\u83cc\u30010.9%\u30d9\u30f3\u30b8\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u4fdd\u5b58\u5e0c\u91c8\u6db2<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 LH\uff0bFSH \u4e21\u7cd6\u30bf\u30f3\u30d1\u30af\u30db\u30eb\u30e2\u30f3\u88fd\u5264 \u2014 \u751f\u7269\u6d3b\u6027\u6bd4 1:1\uff08\u5404 75 IU\uff09<br \/>\n\u2705 LHCGR\uff0bFSHR \u30c7\u30e5\u30a2\u30eb\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u53d7\u5bb9\u4f53\u30a2\u30b4\u30cb\u30b9\u30c8<br \/>\n\u2705 \u9589\u7d4c\u5f8c\u30d7\u30fc\u30eb\u5c3f\u7531\u6765\u306e\u5c3f\u4e2d\u62bd\u51fa\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3\uff08CAS 61489-71-2\uff09<br \/>\n\u2705 2\u7d30\u80de2\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\u30e2\u30c7\u30eb \u2014 \u30e9\u30a4\u30c7\u30a3\u30c3\u30d2\uff0b\u30bb\u30eb\u30c8\u30ea \u307e\u305f\u306f \u83a2\u819c\uff0b\u9846\u7c92\u819c\u7d30\u80de\u306b\u4f5c\u7528<br \/>\n\u2705 Standard tool for spermatogenesis-induction &amp; ovarian-stimulation studies<\/p>\n<p><strong>HMG (Pharmaceutical Grade)<\/strong> \u5c3f\u4e2d\u62bd\u51fa\u30d2\u30c8\u9589\u7d4c\u671f\u30b4\u30ca\u30c9\u30c8\u30ed\u30d4\u30f3\uff08\u30e1\u30ce\u30c8\u30ed\u30d4\u30f3\uff09\u3092\u542b\u6709\u3002<\/p>","protected":false},"featured_media":71453,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6490,6495,6492,6497,6498,6496,6493,6494],"class_list":["post-71441","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-gonadotropin","product_tag-hmg","product_tag-hpg-axis","product_tag-human-menopausal-gonadotropin","product_tag-lhcgr-fshr-agonist","product_tag-menotropin","product_tag-reproductive-research","product_tag-research-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/71441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=71441"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/71453"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=71441"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=71441"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=71441"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=71441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}